Option chain shows key data for Fuse Battery Metals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Fuse Battery Metals.

Fuse Battery Metals (OTC:FUSEF) Stock, Option Chain

Fuse Battery Metals Inc is a Canada-based company engaged in the exploration and development of exploration and evaluation properties. The company currently holds interests in exploration and evaluation properties in the province of Ontario, Canada, and the state of Nevada, USA. Its projects include the Glencore Bucke Cobalt property, Teledyne Cobalt property and Teels Marsh property.

EV Battery Metals Supply Squeeze, Meet Canada’s Cobalt Solutions

Penny Stocks

Emerging Markets

Markets

ELBM

FUSEF

TSLA

TSX:ELBM

Electric vehicle (EV) makers are running into the law of supply and demand when it comes to battery metals:

squeezed SUPPLY + surging DEMAND = rising PRICES

The “surging demand” part in the equation above is easy to understand. 

EV Battery Metals Supply Squeeze, Meet Canada&#39;s Cobalt Solutions

US Inflation Reduction Act Could Supercharge Canada’s Cobalt-Related Sectors

TLSA

The rapidly emerging battery metals market just gained a major driver that will last for decades.

That driver is the US Inflation Reduction Act (IRA), which was passed on August 7, 2022.

US Inflation Reduction Act Could Supercharge Canada&#39;s Cobalt-Related Sectors

News

Tech

General

BYDDY

FUSE

GLNCY

STLA

VWAGY

TSX:FUSE

Cobalt increases battery life and energy density, which in the case of electric vehicles (EVs) means range, by keeping the battery structure stable as the battery is continuously charged and discharged.

The Search For More EV Battery Metals Lands In A Little Town In Canada

FUSE BATTERY METALS INC by FUSE BATTERY METALS INC.

Fuse Battery Metals Inc

B of A Securities analyst Robert Ford maintains MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Buy and raises the price target from $2500 to $3000.

Price Target

Analyst Ratings

MELI

B of A Securities Maintains Buy on MercadoLibre, Raises Price Target to $3000

Benchmark analyst Cody Acree maintains Indie Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) with a Buy and lowers the price target from $9 to $8.

INDI

Benchmark Maintains Buy on Indie Semiconductor, Lowers Price Target to $8

Institutional investors were bullish on technology and financials during the fourth quarter of 2024 as these sectors saw major inflows, according to 13F filings with the Securities Exchange Commission (SEC). Investors were seen pulling back from the healthcare sector.
What Happened: 13F filings are mandatory reports filed by the managers overseeing at least $100 million in assets filed with the SEC. Adam Turnquist, the chief technical strategist at LPL Financial analyses the big rotation in the holdings of such funds for the fourth quarter.
<h3 class="wp-block-heading">Tech&#8217;s Resurgence and Financial Gains</h3>
The results of the U.S. presidential elections, hopes for deregulation, and the possibility of increased lending activity in the wake of Fed rate cuts led the investors to bump their stakes in technology and financials in the fourth quarter according to Turnquist.
After a slight dip in the third quarter, tech holdings surged by 0.7%, reflecting confidence in the sector&#8217;s growth potential. Rotation into financials increased by 0.6%.
&#8220;Communication services and consumer discretionary allocations both increased 0.5% from the third quarter, while allocations toward exchange-traded funds rose 0.4%,&#8221; according to LPL Financial&#8217;s note.
<h3 class="wp-block-heading">Healthcare Under Pressure</h3>
On the other hand, healthcare experienced a sharp decline, with allocations dropping by 1.4%.
This retreat followed a period of stagnation and was likely influenced by political factors. Turnquist said that &#8220;The nomination of the so-called anti-vaccine Health Secretary, Robert F. Kennedy, Jr. and the potential for reduced Affordable Care Act subsidies,&#8221; was also a potential trigger.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Sectors</td>
<td>Changes In Q4</td>
</tr>
<tr>
<td>Technology</td>
<td>0.70%</td>
</tr>
<tr>
<td>Financials</td>
<td>0.60%</td>
</tr>
<tr>
<td>Communications</td>
<td>0.50%</td>
</tr>
<tr>
<td>Consumer Discretionary</td>
<td>0.50%</td>
</tr>
<tr>
<td>Other</td>
<td>0.40%</td>
</tr>
<tr>
<td>Energy</td>
<td>-0.10%</td>
</tr>
<tr>
<td>Industrials</td>
<td>-0.20%</td>
</tr>
<tr>
<td>Utilities</td>
<td>-0.20%</td>
</tr>
<tr>
<td>Consumer Staples</td>
<td>-0.30%</td>
</tr>
<tr>
<td>Materials</td>
<td>-0.30%</td>
</tr>
<tr>
<td>Real Estate</td>
<td>-0.30%</td>
</tr>
<tr>
<td>Health Care</td>
<td>-1.40%</td>
</tr>
</tbody>
</table>
</figure>
See Also: <a href="https://www.benzinga.com/25/02/43876325/quantum-computing-top-holders-in-q4-blackrock-vanguard-ubs-state-street-pour-money-in-rigetti-d-wave-ionq-qubt">Top Holders Of Quantum Computing Stocks In Q4: BlackRock, Vanguard, UBS, State Street Pour Money In Rigetti, D-Wave, IonQ, QUBT</a>
Why It Matters: These filings provide a window into the strategies of major players like hedge funds, pension funds, and endowments.
LPL Research&#8217;s Strategic and Tactical Asset Allocation Committee remains neutral on equities but favors large-cap growth and domestic companies. They also maintain a neutral stance on fixed income, recommending an &#8220;up-in-quality&#8221; approach and cautioning against adding duration due to expected interest rate volatility.
<h3 class="wp-block-heading">Hedge Funds Latgely Follow The Trend</h3>
Hedge funds largely mirrored the broader trend, increasing their tech holdings while reducing exposure to healthcare, according to the note.
Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) were among the top picks, with significant increases in market value. However, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) saw a net selling of 2.1 million shares, and Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) and PDD Holdings Inc. ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) also faced substantial reductions.
While the overall trend was consistent, individual hedge fund strategies varied. While Warren Buffett&#8216;s Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) increased its tech exposure and added Constellation Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) while reducing its stake in Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>).
Conversely, Scion Asset Management, led by Michael Burry, favored healthcare and consumer staples, exiting positions in financials and consumer discretionary.
<h3 class="wp-block-heading">Bond Market Bets And ETF Insights</h3>
Beyond individual stocks, 13F filings revealed that four of the top ten purchased bond ETFs tracked the U.S. bond market. Large-cap growth ETFs also saw significant inflows, indicating a preference for these high-growth stocks, highlighted the note.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43875557/donald-trump-airs-fort-knox-inspection-as-gold-edges-closer-to-3000-it-is-an-essential-component-of-portfolio-says-expert">Gold Is An &#8216;Essential Component&#8217; Of Portfolio, Says Expert As It Nears $3000 While Trump, Musk Suggest Fort Knox Inspection Amid The Surge</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Equities

Government

Hedge Funds

AMZN

MSFT

NVDA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PLTR

Institutional Investors Load Up On Technology And Financial Stocks In Q4 While Reducing Positions In Healthcare Sector Amid Political Uncertainty

B of A Securities analyst Madeline Brooks downgrades Akamai Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) from Buy to Neutral and lowers the price target from $125 to $100.

Downgrades

AKAM

B of A Securities Downgrades Akamai Techs to Neutral, Lowers Price Target to $100

Needham analyst David Saxon maintains Glaukos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) with a Buy and raises the price target from $149 to $176.

GKOS

Needham Maintains Buy on Glaukos, Raises Price Target to $176

<a href="https://x.com/BillAckman/status/1892912458840547554" title="https://x.com/BillAckman/status/1892912458840547554">https://x.com/BillAckman/status/1892912458840547554</a>

Investor Bill Ackman, In Response To Wall Street Journal Report Of DoJ Investigation Into United Health's Medicare Billing Practices, Posted on X He Would Avoid The Stock

Needham analyst James Ricchiuti maintains Universal Display (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>) with a Buy and lowers the price target from $215 to $170.

OLED

Needham Maintains Buy on Universal Display, Lowers Price Target to $170

HC Wainwright &amp; Co. analyst Ed Arce reiterates Ardelyx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARDX#NASDAQ">ARDX</a>) with a Neutral and maintains $5.5 price target.

Reiteration

ARDX

HC Wainwright & Co. Reiterates Neutral on Ardelyx, Maintains $5.5 Price Target

United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.05) by 200 percent. This is a 68.75 percent decrease over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $970.00 million which beat the analyst consensus estimate of $965.87 million by 0.43 percent. This is a 3.00 percent decrease over sales of $1.00 billion the same period last year.

Earnings

Earnings Beats

United States Cellular Q4 2024 GAAP EPS $0.05 Beats $(0.05) Estimate, Sales $970.00M Beat $965.87M Estimate

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) with a Buy and maintains $180 price target.

RGEN

HC Wainwright & Co. Reiterates Buy on Repligen, Maintains $180 Price Target

NIXX

Nixxy Enters Telecommunications And Data Sectors With AI Integration And Software Asset Purchase, Targets $5M Monthly Revenue In Q2

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">TDS Telecom</td>
<td colspan="1" rowspan="1">2025 Estimated Results</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Actual Results for the Year Ended December 31, 2024</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(Dollars in millions)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total operating revenues</td>
<td colspan="1" rowspan="1">$1,030-$1,070</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$1,061</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted OIBDA (Non-GAAP)</td>
<td colspan="1" rowspan="1">$310-$350</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$340</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA&nbsp;(Non-GAAP)</td>
<td colspan="1" rowspan="1">$320-$360</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$350</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital expenditures</td>
<td colspan="1" rowspan="1">$375-$425</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$324</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Telephone and Data Systems' TDS Telecom Segment Expects FY25 Operating Revenue Of $1.03B-$1.07B Vs $1.06B YoY, Capex Of $320M-$360M Vs $350M YoY

Sunstone Hotel Investors Expects FY25 Adjusted FFO Per Share Of $0.86 - $0.98, Est $0.97

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) with a Buy and maintains $28 price target.

BNTC

HC Wainwright & Co. Reiterates Buy on Benitec Biopharma, Maintains $28 Price Target

NCTY

The9 Forms Joint Venture With Chengdu Qing Cheng Network To Expand Mobile Game Operations In China's Sinking Market

Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) with a Hold and raises the price target from $165 to $170.

Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $170

VMAR

Vision Marine Technologies Announced That Its Board Of Directors Has Approved Stock Repurchase Program Authorizing The Repurchase Of Up To 5% Of Company's Issued And Outstanding Common Shares As Of Today

Mizuho analyst Vijay Rakesh maintains Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) with a Neutral and raises the price target from $11 to $13.

RIVN

Mizuho Maintains Neutral on Rivian Automotive, Raises Price Target to $13

Sunstone Hotel Invts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHO#NYSE">SHO</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 15.79 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $214.77 million which beat the analyst consensus estimate of $211.17 million by 1.70 percent. This is a 2.03 percent decrease over sales of $219.22 million the same period last year.

Comments

Fuse Battery Metals

Fuse Battery Metals (FUSEF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga